After a recent myocardial infarction, daily low-dose colchicine reduces the risk for cardiovascular events in patients with type 2 diabetes, a recent study shows.
Aspirin use may reduce growth and progression of abdominal aortic aneurysms in certain patients, with a favorable safety profile, observational data suggest.
A randomized trial evaluating vitamin K therapy with aspirin or placebo with a left ventricular assist device shows avoiding aspirin reduced bleeding without increasing thrombotic risk.
Less than a month of ticagrelor plus aspirin therapy followed by ticagrelor alone for 1 year after PCI for ACS was noninferior to dual antiplatelet therapy in the T-PASS trial.
The large OPT-BIRISK trial adds important information to the complex puzzle of antithrombotic therapy after PCI for acute coronary syndrome, says one expert.